Activation of TLR4 signaling in bladder cancer cells induces tumor-associated PD-L1 expression via activation of Erk and c-Jun N-terminal kinase pathways and protects tumor from CTLs killing (52, 53). This evidence concerns the gene TLR4 and urinary bladder carcinoma.